▶ 調査レポート

世界のアイドラッグ市場 2021:企業別、地域別、種類・用途別

• 英文タイトル:Global Eye Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のアイドラッグ市場 2021:企業別、地域別、種類・用途別 / Global Eye Drug Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-2104Z05385資料のイメージです。• レポートコード:GIR-2104Z05385
• 出版社/出版日:GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。

• レポート形態:英文、PDF、134ページ
• 納品方法:Eメール(納期:2~3日)
• 産業分類:医療・医薬品
• 販売価格(消費税別)
  Single User¥487,200 (USD3,480)▷ お問い合わせ
  Multi User¥730,800 (USD5,220)▷ お問い合わせ
  Corporate User¥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
当調査資料では、アイドラッグのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。アイドラッグの種類別市場規模(ドロップ、タブレット&カプセル)、用途別市場規模(緑内障、網膜疾患、細菌感染症、その他)、地域別市場規模(北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど)、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・アイドラッグの市場概要
・企業情報(企業概要、製品概要、販売量、価格、売上):Pfizer、Novartis、bausch Lomb、Laboratoire Riva、Jamp Pharma、Fresenius、Teva Pharmaceutical?、SANDOZ、Greenstone、Mylan、GE Medical、Mint Pharmaceuticals、Laboratoires Thea、Taj Pharmaceuticals、Actavis、APOTEX、Sun Pharma
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年:ドロップ、タブレット&カプセル
・用途別分析2016年-2026年:緑内障、網膜疾患、細菌感染症、その他
・アイドラッグの北米市場規模2016年-2026年:アメリカ、カナダ、メキシコ
・アイドラッグのヨーロッパ市場規模2016年-2026年:ドイツ、イギリス、フランス、ロシア、イタリア
・アイドラッグのアジア市場規模2016年-2026年:中国、日本、韓国、インド、東南アジア、オーストラリア
・アイドラッグの南米市場規模2016年-2026年:ブラジル、アルゼンチン
・アイドラッグの中東・アフリカ市場規模2016年-2026年:サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Eye Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Eye Drug size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Eye Drug market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Eye Drug market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Drops
Tablet & Capsule

Market segment by Application can be divided into
Glaucoma
Retinal Disease
Bacterial?Infection
Other

The key market players for global Eye Drug market are listed below:
Pfizer
Novartis
bausch Lomb
Laboratoire Riva
Jamp Pharma
Fresenius
Teva Pharmaceutical?
SANDOZ
Greenstone
Mylan
GE Medical
Mint Pharmaceuticals
Laboratoires Thea
Taj Pharmaceuticals
Actavis
APOTEX
Sun Pharma

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Eye Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Eye Drug Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Drops
1.2.3 Tablet & Capsule
1.3 Market Analysis by Application
1.3.1 Overview: Global Eye Drug Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Glaucoma
1.3.3 Retinal Disease
1.3.4 Bacterial?Infection
1.3.5 Other
1.4 Global Eye Drug Market Size & Forecast
1.4.1 Global Eye Drug Sales in Value (2016-2026))
1.4.2 Global Eye Drug Sales in Volume (2016-2026)
1.4.3 Global Eye Drug Price by Type (2016-2026) & (USD/Kg)
1.5 Global Eye Drug Production Capacity Analysis
1.5.1 Global Eye Drug Total Production Capacity (2016-2026)
1.5.2 Global Eye Drug Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Eye Drug Market Drivers
1.6.2 Eye Drug Market Restraints
1.6.3 Eye Drug Trends Analysis
2 Manufacturers Profiles
2.1 Pfizer
2.1.1 Pfizer Details
2.1.2 Pfizer Major Business
2.1.3 Pfizer Eye Drug Product and Services
2.1.4 Pfizer Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Eye Drug Product and Services
2.2.4 Novartis Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 bausch Lomb
2.3.1 bausch Lomb Details
2.3.2 bausch Lomb Major Business
2.3.3 bausch Lomb Eye Drug Product and Services
2.3.4 bausch Lomb Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 Laboratoire Riva
2.4.1 Laboratoire Riva Details
2.4.2 Laboratoire Riva Major Business
2.4.3 Laboratoire Riva Eye Drug Product and Services
2.4.4 Laboratoire Riva Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Jamp Pharma
2.5.1 Jamp Pharma Details
2.5.2 Jamp Pharma Major Business
2.5.3 Jamp Pharma Eye Drug Product and Services
2.5.4 Jamp Pharma Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Fresenius
2.6.1 Fresenius Details
2.6.2 Fresenius Major Business
2.6.3 Fresenius Eye Drug Product and Services
2.6.4 Fresenius Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Teva Pharmaceutical?
2.7.1 Teva Pharmaceutical? Details
2.7.2 Teva Pharmaceutical? Major Business
2.7.3 Teva Pharmaceutical? Eye Drug Product and Services
2.7.4 Teva Pharmaceutical? Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 SANDOZ
2.8.1 SANDOZ Details
2.8.2 SANDOZ Major Business
2.8.3 SANDOZ Eye Drug Product and Services
2.8.4 SANDOZ Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.9 Greenstone
2.9.1 Greenstone Details
2.9.2 Greenstone Major Business
2.9.3 Greenstone Eye Drug Product and Services
2.9.4 Greenstone Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.10 Mylan
2.10.1 Mylan Details
2.10.2 Mylan Major Business
2.10.3 Mylan Eye Drug Product and Services
2.10.4 Mylan Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.11 GE Medical
2.11.1 GE Medical Details
2.11.2 GE Medical Major Business
2.11.3 GE Medical Eye Drug Product and Services
2.11.4 GE Medical Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.12 Mint Pharmaceuticals
2.12.1 Mint Pharmaceuticals Details
2.12.2 Mint Pharmaceuticals Major Business
2.12.3 Mint Pharmaceuticals Eye Drug Product and Services
2.12.4 Mint Pharmaceuticals Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.13 Laboratoires Thea
2.13.1 Laboratoires Thea Details
2.13.2 Laboratoires Thea Major Business
2.13.3 Laboratoires Thea Eye Drug Product and Services
2.13.4 Laboratoires Thea Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.14 Taj Pharmaceuticals
2.14.1 Taj Pharmaceuticals Details
2.14.2 Taj Pharmaceuticals Major Business
2.14.3 Taj Pharmaceuticals Eye Drug Product and Services
2.14.4 Taj Pharmaceuticals Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.15 Actavis
2.15.1 Actavis Details
2.15.2 Actavis Major Business
2.15.3 Actavis Eye Drug Product and Services
2.15.4 Actavis Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.16 APOTEX
2.16.1 APOTEX Details
2.16.2 APOTEX Major Business
2.16.3 APOTEX Eye Drug Product and Services
2.16.4 APOTEX Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.17 Sun Pharma
2.17.1 Sun Pharma Details
2.17.2 Sun Pharma Major Business
2.17.3 Sun Pharma Eye Drug Product and Services
2.17.4 Sun Pharma Eye Drug Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Eye Drug Sales by Manufacturer
3.1 Global Eye Drug Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Eye Drug Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Eye Drug
3.4 Market Concentration Rate
3.4.1 Top 3 Eye Drug Manufacturer Market Share
3.4.2 Top 6 Eye Drug Manufacturer Market Share
3.5 Global Eye Drug Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Eye Drug Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Eye Drug Market Size by Region
4.1.1 Global Eye Drug Sales in Volume by Region (2016-2026)
4.1.2 Global Eye Drug Revenue by Region (2016-2026)
4.2 North America Eye Drug Revenue (2016-2026)
4.3 Europe Eye Drug Revenue (2016-2026)
4.4 Asia-Pacific Eye Drug Revenue (2016-2026)
4.5 South America Eye Drug Revenue (2016-2026)
4.6 Middle East and Africa Eye Drug Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Eye Drug Sales in Volume by Type (2016-2026)
5.2 Global Eye Drug Revenue by Type (2016-2026)
5.3 Global Eye Drug Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Eye Drug Sales in Volume by Application (2016-2026)
6.2 Global Eye Drug Revenue by Application (2016-2026)
6.3 Global Eye Drug Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Eye Drug Sales by Type (2016-2026)
7.2 North America Eye Drug Sales by Application (2016-2026)
7.3 North America Eye Drug Market Size by Country
7.3.1 North America Eye Drug Sales in Volume by Country (2016-2026)
7.3.2 North America Eye Drug Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Eye Drug Sales by Type (2016-2026)
8.2 Europe Eye Drug Sales by Application (2016-2026)
8.3 Europe Eye Drug Market Size by Country
8.3.1 Europe Eye Drug Sales in Volume by Country (2016-2026)
8.3.2 Europe Eye Drug Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Eye Drug Sales by Type (2016-2026)
9.2 Asia-Pacific Eye Drug Sales by Application (2016-2026)
9.3 Asia-Pacific Eye Drug Market Size by Region
9.3.1 Asia-Pacific Eye Drug Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Eye Drug Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Eye Drug Sales by Type (2016-2026)
10.2 South America Eye Drug Sales by Application (2016-2026)
10.3 South America Eye Drug Market Size by Country
10.3.1 South America Eye Drug Sales in Volume by Country (2016-2026)
10.3.2 South America Eye Drug Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Eye Drug Sales by Type (2016-2026)
11.2 Middle East & Africa Eye Drug Sales by Application (2016-2026)
11.3 Middle East & Africa Eye Drug Market Size by Country
11.3.1 Middle East & Africa Eye Drug Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Eye Drug Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Eye Drug Typical Distributors
12.3 Eye Drug Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Eye Drug Revenue by Type, (USD Million), 2021-2026
Table 2. Global Eye Drug Revenue by Application, (USD Million), 2021-2026
Table 3. Pfizer Basic Information, Manufacturing Base and Competitors
Table 4. Pfizer Major Business
Table 5. Pfizer Eye Drug Product and Services
Table 6. Pfizer Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Novartis Basic Information, Manufacturing Base and Competitors
Table 8. Novartis Major Business
Table 9. Novartis Eye Drug Product and Services
Table 10. Novartis Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. bausch Lomb Basic Information, Manufacturing Base and Competitors
Table 12. bausch Lomb Major Business
Table 13. bausch Lomb Eye Drug Product and Services
Table 14. bausch Lomb Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. Laboratoire Riva Basic Information, Manufacturing Base and Competitors
Table 16. Laboratoire Riva Major Business
Table 17. Laboratoire Riva Eye Drug Product and Services
Table 18. Laboratoire Riva Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Jamp Pharma Basic Information, Manufacturing Base and Competitors
Table 20. Jamp Pharma Major Business
Table 21. Jamp Pharma Eye Drug Product and Services
Table 22. Jamp Pharma Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Fresenius Basic Information, Manufacturing Base and Competitors
Table 24. Fresenius Major Business
Table 25. Fresenius Eye Drug Product and Services
Table 26. Fresenius Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Teva Pharmaceutical? Basic Information, Manufacturing Base and Competitors
Table 28. Teva Pharmaceutical? Major Business
Table 29. Teva Pharmaceutical? Eye Drug Product and Services
Table 30. Teva Pharmaceutical? Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. SANDOZ Basic Information, Manufacturing Base and Competitors
Table 32. SANDOZ Major Business
Table 33. SANDOZ Eye Drug Product and Services
Table 34. SANDOZ Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Greenstone Basic Information, Manufacturing Base and Competitors
Table 36. Greenstone Major Business
Table 37. Greenstone Eye Drug Product and Services
Table 38. Greenstone Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 39. Mylan Basic Information, Manufacturing Base and Competitors
Table 40. Mylan Major Business
Table 41. Mylan Eye Drug Product and Services
Table 42. Mylan Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 43. GE Medical Basic Information, Manufacturing Base and Competitors
Table 44. GE Medical Major Business
Table 45. GE Medical Eye Drug Product and Services
Table 46. GE Medical Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 47. Mint Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 48. Mint Pharmaceuticals Major Business
Table 49. Mint Pharmaceuticals Eye Drug Product and Services
Table 50. Mint Pharmaceuticals Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 51. Laboratoires Thea Basic Information, Manufacturing Base and Competitors
Table 52. Laboratoires Thea Major Business
Table 53. Laboratoires Thea Eye Drug Product and Services
Table 54. Laboratoires Thea Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 55. Taj Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 56. Taj Pharmaceuticals Major Business
Table 57. Taj Pharmaceuticals Eye Drug Product and Services
Table 58. Taj Pharmaceuticals Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 59. Actavis Basic Information, Manufacturing Base and Competitors
Table 60. Actavis Major Business
Table 61. Actavis Eye Drug Product and Services
Table 62. Actavis Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 63. APOTEX Basic Information, Manufacturing Base and Competitors
Table 64. APOTEX Major Business
Table 65. APOTEX Eye Drug Product and Services
Table 66. APOTEX Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 67. Sun Pharma Basic Information, Manufacturing Base and Competitors
Table 68. Sun Pharma Major Business
Table 69. Sun Pharma Eye Drug Product and Services
Table 70. Sun Pharma Eye Drug Sales (MT), Price (USD/Kg), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 71. Global Eye Drug Sales by Manufacturer (2019-2021e) & (MT)
Table 72. Global Eye Drug Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 73. Market Position of Manufacturers in Eye Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 74. Global Eye Drug Production Capacity by Company, (MT): 2020 VS 2021
Table 75. Head Office and Eye Drug Production Site of Key Manufacturer
Table 76. Global Eye Drug Sales by Region (2016-2021e) & (MT)
Table 77. Global Eye Drug Sales by Region (2021-2026) & (MT)
Table 78. Global Eye Drug Revenue by Region (2016-2021e) & (USD Million)
Table 79. Global Eye Drug Revenue by Region (2021-2026) & (USD Million)
Table 80. Global Eye Drug Sales by Type (2016-2021e) & (MT)
Table 81. Global Eye Drug Sales by Type (2021-2026) & (MT)
Table 82. Global Eye Drug Revenue by Type (2016-2021e) & (USD Million)
Table 83. Global Eye Drug Revenue by Type (2021-2026) & (USD Million)
Table 84. Global Eye Drug Price by Type (2016-2021e) & (USD/Kg)
Table 85. Global Eye Drug Price by Type (2021-2026) & (USD/Kg)
Table 86. Global Eye Drug Sales by Application (2016-2021e) & (MT)
Table 87. Global Eye Drug Sales by Application (2021-2026) & (MT)
Table 88. Global Eye Drug Revenue by Application (2016-2021e) & (USD Million)
Table 89. Global Eye Drug Revenue by Application (2021-2026) & (USD Million)
Table 90. Global Eye Drug Price by Application (2016-2021e) & (USD/Kg)
Table 91. Global Eye Drug Price by Application (2021-2026) & (USD/Kg)
Table 92. North America Eye Drug Sales by Country (2016-2021e) & (MT)
Table 93. North America Eye Drug Sales by Country (2021-2026) & (MT)
Table 94. North America Eye Drug Revenue by Country (2016-2021e) & (USD Million)
Table 95. North America Eye Drug Revenue by Country (2021-2026) & (USD Million)
Table 96. North America Eye Drug Sales by Type (2016-2021e) & (MT)
Table 97. North America Eye Drug Sales by Type (2021-2026) & (MT)
Table 98. North America Eye Drug Sales by Application (2016-2021e) & (MT)
Table 99. North America Eye Drug Sales by Application (2021-2026) & (MT)
Table 100. Europe Eye Drug Sales by Country (2016-2021e) & (MT)
Table 101. Europe Eye Drug Sales by Country (2021-2026) & (MT)
Table 102. Europe Eye Drug Revenue by Country (2016-2021e) & (USD Million)
Table 103. Europe Eye Drug Revenue by Country (2021-2026) & (USD Million)
Table 104. Europe Eye Drug Sales by Type (2016-2021e) & (MT)
Table 105. Europe Eye Drug Sales by Type (2021-2026) & (MT)
Table 106. Europe Eye Drug Sales by Application (2016-2021e) & (MT)
Table 107. Europe Eye Drug Sales by Application (2021-2026) & (MT)
Table 108. Asia-Pacific Eye Drug Sales by Region (2016-2021e) & (MT)
Table 109. Asia-Pacific Eye Drug Sales by Region (2021-2026) & (MT)
Table 110. Asia-Pacific Eye Drug Revenue by Region (2016-2021e) & (USD Million)
Table 111. Asia-Pacific Eye Drug Revenue by Region (2021-2026) & (USD Million)
Table 112. Asia-Pacific Eye Drug Sales by Type (2016-2021e) & (MT)
Table 113. Asia-Pacific Eye Drug Sales by Type (2021-2026) & (MT)
Table 114. Asia-Pacific Eye Drug Sales by Application (2016-2021e) & (MT)
Table 115. Asia-Pacific Eye Drug Sales by Application (2021-2026) & (MT)
Table 116. South America Eye Drug Sales by Country (2016-2021e) & (MT)
Table 117. South America Eye Drug Sales by Country (2021-2026) & (MT)
Table 118. South America Eye Drug Revenue by Country (2016-2021e) & (USD Million)
Table 119. South America Eye Drug Revenue by Country (2021-2026) & (USD Million)
Table 120. South America Eye Drug Sales by Type (2016-2021e) & (MT)
Table 121. South America Eye Drug Sales by Type (2021-2026) & (MT)
Table 122. South America Eye Drug Sales by Application (2016-2021e) & (MT)
Table 123. South America Eye Drug Sales by Application (2021-2026) & (MT)
Table 124. Middle East & Africa Eye Drug Sales by Country (2016-2021e) & (MT)
Table 125. Middle East & Africa Eye Drug Sales by Country (2021-2026) & (MT)
Table 126. Middle East & Africa Eye Drug Revenue by Country (2016-2021e) & (USD Million)
Table 127. Middle East & Africa Eye Drug Revenue by Country (2021-2026) & (USD Million)
Table 128. Middle East & Africa Eye Drug Sales by Type (2016-2021e) & (MT)
Table 129. Middle East & Africa Eye Drug Sales by Type (2021-2026) & (MT)
Table 130. Middle East & Africa Eye Drug Sales by Application (2016-2021e) & (MT)
Table 131. Middle East & Africa Eye Drug Sales by Application (2021-2026) & (MT)
Table 132. Direct Channel Pros & Cons
Table 133. Indirect Channel Pros & Cons
Table 134. Eye Drug Typical Distributors
Table 135. Eye Drug Typical Customers
List of Figures
Figure 1. Eye Drug Picture
Figure 2. Global Eye Drug Sales Market Share by Type in 2020
Figure 3. Drops
Figure 4. Tablet & Capsule
Figure 5. Global Eye Drug Sales Market Share by Application in 2020
Figure 6. Glaucoma
Figure 7. Retinal Disease
Figure 8. Bacterial?Infection
Figure 9. Other
Figure 10. Global Eye Drug Market Size, (USD Million) & (MT): 2020 VS 2021 VS 2026
Figure 11. Global Eye Drug Market Size and Forecast (2016-2026) & (USD Million)
Figure 12. United States Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Canada Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Mexico Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Germany Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. France Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. United Kingdom Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Russia Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Italy Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. China Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Japan Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Korea Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. India Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Southeast Asia Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Australia Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Brazil Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Egypt Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Saudi Arabia Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. South Africa Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Turkey Eye Drug Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Global Eye Drug Sales (2016-2026) & (MT)
Figure 32. Global Eye Drug Production Capacity (2016-2026) & (MT)
Figure 33. Global Eye Drug Production Capacity by Geographic Region: 2020 VS 2021
Figure 34. Eye Drug Market Drivers
Figure 35. Eye Drug Market Restraints
Figure 36. Eye Drug Market Trends
Figure 37. Global Eye Drug Sales Market Share by Manufacturer in 2020
Figure 38. Global Eye Drug Revenue Market Share by Manufacturer in 2020
Figure 39. Eye Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 40. Top 3 Eye Drug Manufacturer (Revenue) Market Share in 2020
Figure 41. Top 6 Eye Drug Manufacturer (Revenue) Market Share in 2020
Figure 42. Global Eye Drug Sales Market Share by Region (2016-2026)
Figure 43. Global Eye Drug Revenue Market Share by Region (2016-2026)
Figure 44. North America Eye Drug Revenue (2016-2026) & (USD Million)
Figure 45. Europe Eye Drug Revenue (2016-2026) & (USD Million)
Figure 46. Asia-Pacific Eye Drug Revenue (2016-2026) & (USD Million)
Figure 47. South America Eye Drug Revenue (2016-2026) & (USD Million)
Figure 48. Middle East & Africa Eye Drug Revenue (2016-2026) & (USD Million)
Figure 49. Global Eye Drug Sales Market Share by Type (2016-2026)
Figure 50. Global Eye Drug Revenue Market Share by Type (2016-2026)
Figure 51. Global Eye Drug Price by Type (2016-2026) & (USD/Kg)
Figure 52. Global Eye Drug Sales Market Share by Application (2016-2026)
Figure 53. Global Eye Drug Revenue Market Share by Application (2016-2026)
Figure 54. Global Eye Drug Price by Application (2016-2026) & (USD/Kg)
Figure 55. North America Eye Drug Sales Market Share by Country (2016-2026)
Figure 56. North America Eye Drug Revenue Market Share by Country (2016-2026)
Figure 57. North America Eye Drug Sales Market Share by Type (2016-2026)
Figure 58. North America Eye Drug Sales Market Share by Application (2016-2026)
Figure 59. Europe Eye Drug Sales Market Share by Country (2016-2026)
Figure 60. Europe Eye Drug Revenue Market Share by Country (2016-2026)
Figure 61. Europe Eye Drug Sales Market Share by Type (2016-2026)
Figure 62. Europe Eye Drug Sales Market Share by Application (2016-2026)
Figure 63. Asia-Pacific Eye Drug Sales Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Eye Drug Revenue Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Eye Drug Sales Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Eye Drug Sales Market Share by Application (2016-2026)
Figure 67. South America Eye Drug Sales Market Share by Country (2016-2026)
Figure 68. South America Eye Drug Revenue Market Share by Country (2016-2026)
Figure 69. South America Eye Drug Sales Market Share by Type (2016-2026)
Figure 70. South America Eye Drug Sales Market Share by Application (2016-2026)
Figure 71. Middle East & Africa Eye Drug Sales Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Eye Drug Revenue Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Eye Drug Sales Market Share by Type (2016-2026)
Figure 74. Middle East & Africa Eye Drug Sales Market Share by Application (2016-2026)
Figure 75. Sales Channel: Direct Channel vs Indirect Channel
Figure 76. Methodology
Figure 77. Research Process and Data Source